10-Q: Celanese Q2 Earnings Hit by Weak Demand, Boosted by Tax Gains
Quarterly Report
Celanese Corporation reports a decline in net sales and operating profit for Q2 and H1 2025 due to weak global demand and competitive pricing, partially offset by significant tax benefits and cost savings.
Summary
- Net sales decreased by $119 million (4%) to $2,532 million for Q2 2025 and by $341 million (6%) to $4,921 million for H1 2025, compared to the same periods in 2024.
- Operating profit declined by $17 million (7%) to $233 million for Q2 2025 and by $59 million (13%) to $401 million for H1 2025.
- Net earnings attributable to Celanese Corporation increased by $44 million to $199 million for Q2 2025, but decreased by $98 million to $178 million for H1 2025.
- The effective income tax rate was a benefit of 57% for Q2 2025 and 52% for H1 2025, primarily due to a net deferred tax benefit from intangible asset relocation and a German tax settlement.
- Equity in net earnings of affiliates decreased by $22 million (43%) for Q2 2025 and by $55 million (52%) for H1 2025, mainly due to lower MTBE volume and pricing from the Ibn Sina affiliate.
- The company is actively deleveraging, having reduced its quarterly dividend by approximately 95% starting Q1 2025, and completed a $2.55 billion public offering of senior unsecured notes in March 2025.
- Total debt as of June 30, 2025, was $12,941 million, up from $12,579 million as of December 31, 2024.
- Cash and cash equivalents increased by $211 million to $1,173 million as of June 30, 2025.
- Net cash provided by operating activities increased by $54 million to $447 million for H1 2025, driven by favorable trade working capital.
- Capital expenditures are expected to be approximately $300 million to $350 million in 2025, with some projects delayed to align with demand growth and capital reductions.
Sentiment
Score: 4
Explanation: The overall sentiment is moderately negative. While the company demonstrated strong financial management through debt refinancing and significant tax benefits, the underlying operational performance, characterized by declining sales, operating profit, and affiliate earnings due to weak demand and competitive pricing, indicates a challenging business environment. The delays in capital projects and the expectation of continued sluggish demand further contribute to a cautious outlook, despite active deleveraging efforts.
Positives
- Net earnings attributable to Celanese Corporation increased by $44 million to $199 million for the three months ended June 30, 2025, compared to $155 million in the prior year period.
- A significant income tax benefit of 57% for Q2 2025 and 52% for H1 2025, driven by a net deferred tax benefit from intangible asset relocation and a German tax settlement, positively impacted net earnings.
- Operating profit in the Engineered Materials segment increased by 19.6% for Q2 2025 and 15.0% for H1 2025, primarily due to lower spending, reduced raw material costs, and non-recurring restructuring costs from the prior period.
- Lower spending of $30 million in Q2 2025 and $71 million in H1 2025, primarily from synergy realization and cost savings actions, contributed positively to operating profit.
- Favorable trade working capital of $203 million for H1 2025, due to inventory reductions and timing of trade payables, increased net cash provided by operating activities.
- Dividend income from equity investments increased by $10 million (32%) for Q2 2025, primarily due to a change in dividend timing from the Nantong Cellulose Fibers affiliate.
- The company successfully completed a $2.55 billion public offering of senior unsecured notes and cash tender offers, demonstrating effective debt management and refinancing capabilities.
- A new $1.75 billion senior unsecured revolving credit facility maturing in 2030 replaced the previous facility, enhancing liquidity and extending maturity.
Negatives
- Net sales decreased by 4% for Q2 2025 and 6% for H1 2025, primarily due to lower pricing and reduced volume across both Engineered Materials and Acetyl Chain segments.
- Operating profit decreased by 7% for Q2 2025 and 13% for H1 2025, mainly due to lower net sales.
- Equity in net earnings of affiliates decreased significantly by 43% for Q2 2025 and 52% for H1 2025, largely due to lower MTBE volume and pricing, and higher feedstock costs from the Ibn Sina strategic affiliate.
- The Acetyl Chain segment experienced a substantial decline in operating profit, down 36.4% for Q2 2025 and 36.3% for H1 2025, driven by lower net sales and higher plant turnaround costs.
- Credit rating downgrades by S&P Global Ratings (November 2024) and Moody's Ratings (February 2025) increased interest rates by up to 50 basis points on certain senior unsecured notes and 25-30 basis points on U.S. Credit Agreements.
- The company incurred $32 million in refinancing expense related to the Tender Offers, including accelerated amortization of deferred financing costs.
- Demand challenges persist in key end-markets such as automotive, paints, coatings, and construction due to tepid global macroeconomic conditions.
- The company expects the weakened demand environment to continue to adversely impact cash generation in the near-term.
Risks
- Changes in general economic, business, political, and regulatory conditions in operating countries or regions.
- Length and depth of product and industry business cycles, particularly in automotive, electrical, textiles, electronics, and construction industries.
- Volatility or changes in the price and availability of raw materials and energy, including ethylene, methanol, natural gas, and fuel oil.
- Ability to pass increases in raw materials prices, logistics costs, and other costs on to customers or otherwise improve margins.
- Inability to realize anticipated benefits of the Mobility & Materials (M&M) business acquisition, including synergies and growth opportunities.
- Additional impairments of goodwill or intangible assets.
- Increased commercial, legal, or regulatory complexity in entering or expanding exposure to certain end markets and geographies.
- Risks in the global economy and equity and credit markets impacting the ability to pay down or refinance debt at suitable rates.
- Risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility.
- Ability to maintain plant utilization rates and implement planned capacity additions, expansions, and maintenance.
- Increased price competition and introduction of competing products by other companies.
- Compliance and other costs, and potential disruption or interruption of production or operations due to accidents, raw material interruptions, supply chain disruptions, cybersecurity incidents, terrorism, political unrest, public health crises, or geopolitical conflicts.
- Changes in applicable tariffs, duties, trade agreements, tax rates, or legislation, and the resolution of tax examinations or audits.
- Changes in intellectual property and other legal protection afforded to products or technologies, or theft of such intellectual property.
- Potential liability for remedial actions and increased costs under existing or future environmental, health, and safety regulations, including climate change or sustainability matters.
- Potential liability resulting from pending or future claims or litigation, including antitrust/competition law investigations and environmental remediation (e.g., Diamond Alkali Superfund Site, Lower Passaic River Site).
- Level of indebtedness, which could diminish ability to raise additional capital or limit reaction to economic/industry changes, and the success of deleveraging efforts.
- Changes in currency exchange rates and interest rates.
- Capital controls and exchange restrictions imposed by local governments in certain jurisdictions (e.g., China, South Korea, India, Indonesia) limiting cash repatriation or intercompany transfers.
Future Outlook
The company anticipates demand conditions to remain sluggish in the third quarter of 2025 and will continue to monitor the impact of tariffs and geopolitical effects. It expects to continue deleveraging efforts, prioritizing maintenance projects and productivity improvements for capital expenditures, with total capital expenditures projected to be $300 million to $350 million in 2025. The China Credit Agreements are expected to facilitate efficient cash repatriation to the U.S. for debt repayment at lower average interest rates. The company is evaluating tax planning strategies to utilize foreign tax credit carryforwards and does not expect the One Big Beautiful Bill Act (OBBBA) to have a material impact on future effective tax rates and cash taxes in the short term due to safe harbor provisions.
Management Comments
- We are actively managing our business to maintain cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.
- We expect the weakened demand environment to continue to adversely impact our cash generation in the near-term.
- We will continue to evaluate our dividend policy, taking into account our ability to return to a balanced capital allocation strategy.
- We continue to focus our near-term capital expenditures on required maintenance projects and productivity improvements, as we continue to prioritize deleveraging.
- We continue to see the investments made in recent years strengthen the growth and reliability, while lowering the carbon footprint, of our manufacturing network to best serve our customers.
- We remain in compliance with the covenants in the existing Global Credit Agreements and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities.
- We remain committed to identifying and implementing actions to improve long-term growth and value creation.
Industry Context
The company operates in the global chemical and specialty materials industry, producing high-performance engineered polymers and acetyl products. Its performance is significantly impacted by macroeconomic conditions and business cycles in key end-markets such as automotive, chemical additives, construction, consumer electronics, and textiles. The current environment is characterized by weaker global economic conditions, decreased global demand, and competitive market dynamics, leading to lower pricing and volume, particularly in the Acetyl Chain segment due to oversupply. The company's strategic focus on differentiated business models, operational excellence, and global production capacity aims to mitigate these industry headwinds.
Comparison to Industry Standards
- The decline in net sales and operating profit across both Engineered Materials and Acetyl Chain segments reflects a challenging global macroeconomic environment, consistent with broader trends impacting chemical and specialty materials companies exposed to cyclical end-markets like automotive and construction.
- The Acetyl Chain segment's lower pricing due to an environment with greater supply than demand indicates an industry-wide oversupply situation, which has pressured margins for many commodity chemical producers.
- The decrease in earnings from the Ibn Sina strategic affiliate due to lower MTBE volume and pricing, and higher feedstock costs, aligns with the volatile nature of petrochemical markets and the impact of global energy prices on chemical production costs.
- The company's proactive deleveraging efforts, including dividend reduction and debt refinancing, are common strategies employed by companies in capital-intensive industries facing economic headwinds and aiming to strengthen their balance sheets amidst rising interest rates and credit rating pressures.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaws/Certificate of Incorporation Amendment | A Certificate of Elimination was filed eliminating all provisions relating to a previously redeemed class of Preferred stock, of which no shares were outstanding. Restated Certificate of Incorporation and Amended and Restated By-laws became effective. | 2025-05-15 | Streamlines corporate charter by removing obsolete provisions related to preferred stock and updates governing documents, reflecting standard corporate housekeeping. |
| Credit Agreement Covenants Amendment | Amended certain covenants in certain U.S. Credit Agreements, including financial ratio maintenance covenants. | 2025-02-17 | Adjusts financial obligations and flexibility under credit facilities, potentially easing compliance requirements or reflecting changes in financial strategy. |
| Credit Agreement Covenants Amendment | Amended the March 2022 U.S. Credit Agreement to add or modify financial ratio covenants and other provisions. | 2025-08-11 | Further adjusts financial obligations and flexibility under the term loan, likely in response to current financial performance or strategic objectives. |
Legal Proceedings
- Ongoing environmental remediation liabilities related to demerger obligations, divestiture obligations, active sites, and U.S. Superfund sites (e.g., Diamond Alkali Superfund Site, Lower Passaic River Site).
- The company is a party to the 2018 OCC Lawsuit and the 2023 OCC Lawsuit concerning cleanup costs at the Lower Passaic River Site, with the 2018 lawsuit stayed pending judicial approval of a Consent Decree.
- The U.S. District Court for the District of New Jersey granted the United States' motion to enter the Consent Decree in the Consent Decree Action on December 18, 2024, resolving the company's liability to the EPA for Lower Passaic River Site cleanup costs for a collective payment of $150 million.
- Appeals have been filed by Nokia of America Corporation and OCC against the entry of the Consent Decree.
- Ongoing legal and regulatory proceedings, lawsuits, claims, and investigations incidental to normal business conduct, including product liability, land disputes, insurance coverage, contracts, employment, antitrust, intellectual property, personal injury, toxic tort, public nuisance, workers' compensation, chemical/asbestos exposure, taxes, trade compliance, acquisitions/divestitures, and shareholder claims.
- The company is defending against separate claims for damages filed by Shell Chemicals Europe, TotalEnergies Petrochemicals & Refining SA, OMV Aktiengesellschaft, Borealis GMBH, Lyondell Basell, BASF SE, and Dow Europe GmbH in European courts related to a settled European Commission competition law investigation involving past ethylene purchases.
Related Party Transactions
- The company's largest exposure to a country with capital controls is in China, where foreign-invested enterprises may pay dividends only out of accumulated profits and the government imposes currency exchange controls on cash transfers, limitations on intercompany loans, and restrictions on cross-border cash pooling. These limitations do not currently restrict operations.
- The company transfers cash among the Parent Guarantor, Issuer, Subsidiary Guarantors, and non-guarantors through intercompany financing arrangements, contributions, or declaration of dividends for cash management purposes.
Stakeholder Impact
- Shareholders: Impacted by the 95% reduction in quarterly dividends, reflecting a shift in capital allocation strategy towards deleveraging. Net earnings per share were mixed, up for Q2 but down for H1.
- Creditors: Affected by credit rating downgrades which increased interest rates on certain debt, but also by active debt management including tender offers and new debt offerings aimed at improving the debt maturity profile and reducing leverage.
- Employees: Impacted by company-wide business optimization projects and restructuring, which include employee termination benefits.
- Customers: Affected by lower pricing and volumes due to competitive market dynamics and weaker global economic conditions, potentially benefiting from more competitive pricing but facing reduced demand.
- Suppliers: May experience reduced demand for raw materials due to lower production volumes and efforts to reduce inventory.
Next Steps
- Continue to closely monitor the impact of, and response to, tariffs and other geopolitical effects on demand conditions.
- Evaluate tax planning strategies to enable the use of foreign tax credit carryforwards.
- Continue to monitor the developments and implementation of the OECD BEPS projects.
- Continue discussions with the U.S. tax authority on joint audit matters and other separate matters.
- Continue discussions with the Mexican tax authorities regarding preliminary findings in the 2019 audit.
- Continue ongoing discussions regarding audit findings with the Canadian tax authorities for the years 2016 through 2018.
- Complete construction of the compounding plant expansion at the Nanjing, China facility by Q3 2025.
- Start up the VAE emulsion plant expansion in Frankfurt, Germany by Q3 2025.
- Complete construction of the new liquid crystal polymer (LCP) plant at the Nanjing, China facility by H2 2026.
- Continue to evaluate the dividend policy, taking into account the ability to return to a balanced capital allocation strategy.
- Potentially pursue other opportunistic dispositions or monetization of other product or business lines or other assets as part of deleveraging efforts.
Key Dates
| Date | Description |
|---|---|
| 2008-02-01 | Beginning of the Board of Directors' repurchase authorizations for Common Stock. |
| 2022-03-01 | Celanese, Celanese U.S., and certain subsidiaries entered into a term loan credit agreement (March 2022 U.S. Term Loan Credit Agreement) and a new revolving credit agreement (U.S. Revolving Credit Agreement). |
| 2022-11-01 | Acquisition of Mobility & Materials (M&M) business from DuPont de Nemours, Inc. |
| 2022-11-01 | S&P Global Ratings downgraded the company's credit rating to BB+. |
| 2022-12-01 | U.S. District Court for the District of New Jersey lodged a Consent Decree resolving the company's liability for cleanup costs at the Lower Passaic River Site. |
| 2023-01-01 | Celanese (Shanghai) International Trading Co., Ltd (CSIT) entered into an amendment and restatement of an existing credit facility agreement (CSIT Revolving Credit Agreement) and a senior unsecured working capital loan contract (January 2023 CSIT One Year Working Capital Term Loan Agreement). |
| 2023-03-01 | U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit. |
| 2023-03-01 | OCC filed a new lawsuit (2023 OCC Lawsuit) against 40 parties, including a subsidiary of the company, seeking to recover costs for remedial design work for a portion of the LPRSA. |
| 2023-08-01 | Partial settlement negotiated with Mexico tax authorities for the 2018 audit year. |
| 2023-09-01 | Canadian tax authorities opened tax audits for the years 2019 through 2022. |
| 2023-12-01 | Celanese (Nanjing) Chemical Co., Ltd. (CNC) entered into a senior unsecured working capital loan agreement (December 2023 CNC Three Year Working Capital Loan Agreement). |
| 2024-02-16 | Company amended certain covenants in certain U.S. Credit Agreements. |
| 2024-04-01 | CSIT January 2023 Facility was reduced to CNY750 million. |
| 2024-06-01 | CNC entered into a senior unsecured working capital loan agreement (June 2024 CNC Three Year Working Capital Loan Agreement). |
| 2024-11-01 | Company amended certain covenants in certain U.S. Credit Agreements. |
| 2024-11-01 | Company announced intent to reduce quarterly dividend by approximately 95% beginning Q1 2025. |
| 2024-11-01 | Celanese U.S. entered into a senior unsecured term loan credit agreement (November 2024 U.S. Term Loan Credit Agreement). |
| 2024-12-01 | CSIT January 2023 Facility was reduced to CNY550 million. |
| 2024-12-01 | CNC entered into a senior unsecured working capital loan agreement (December 2024 CNC Three Year Working Capital Loan Agreement). |
| 2024-12-18 | U.S. District Court for the District of New Jersey granted the United States' motion to enter the Consent Decree in the Consent Decree Action. |
| 2025-02-12 | Moody's Ratings downgraded the company's credit ratings to Ba1. |
| 2025-02-17 | Company amended certain covenants in certain U.S. Credit Agreements. |
| 2025-03-06 | CNC entered into a senior unsecured working capital loan agreement (March 2025 CNC Three Year Working Capital Loan Agreement). |
| 2025-03-14 | Celanese U.S. completed a public offering of senior unsecured notes (2025 Offering). |
| 2025-03-15 | Remaining commitments under the November 2024 U.S. Term Loan Credit Agreement terminated. |
| 2025-03-17 | Company entered into a cross-currency swap to convert $400 million of issued senior unsecured notes due 2030 into a Japanese yen-denominated borrowing. |
| 2025-03-21 | Celanese U.S. completed cash tender offers for $552 million and $500 million in aggregate principal amounts of notes. |
| 2025-05-05 | Company announced intent to divest its Micromax portfolio of products. |
| 2025-05-15 | Company filed a Certificate of Elimination for a previously redeemed class of Preferred stock and Restated Certificate of Incorporation and Amended and Restated By-laws became effective. |
| 2025-06-13 | Company entered into an amendment to the amended and restated receivables purchase agreement under its U.S. accounts receivable purchasing facility. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-16 | Company declared a quarterly cash dividend of $0.03 per share on its Common Stock. |
| 2025-07-29 | Record date for the quarterly cash dividend declared on July 16, 2025. |
| 2025-07-30 | $150 million of outstanding amount under the March 2022 U.S. Term Loan Credit Agreement was repaid. |
| 2025-08-04 | Number of outstanding shares of Common Stock was 109,503,729. |
| 2025-08-11 | Payment date for the quarterly cash dividend declared on July 16, 2025. |
| 2025-08-11 | Celanese, Celanese U.S., and certain subsidiaries entered into a new revolving credit agreement, replacing the U.S. Revolving Credit Facility. |
| 2025-08-11 | Company amended the March 2022 U.S. Credit Agreement to add or modify financial ratio covenants and other provisions. |
| 2025-09-30 | Expected completion of the compounding plant expansion at Nanjing, China facility. |
| 2025-09-30 | Expected start-up of the VAE emulsion plant expansion in Frankfurt, Germany. |
| 2026-06-17 | Extended term of the U.S. accounts receivable purchasing facility. |
| 2026-12-31 | Expected completion of the new liquid crystal polymer (LCP) plant at Nanjing, China facility. |
Recommendation
holdWhile Celanese is navigating a challenging macroeconomic environment with declining sales and operating profits in its core segments, the company is proactively addressing its financial health through aggressive deleveraging, including a significant dividend reduction and successful debt refinancing. The substantial tax benefits in the current period are non-recurring but provide a temporary boost to net earnings. The long-term growth projects in Engineered Materials are progressing, albeit with some delays. The company's strong liquidity position and commitment to cost savings are positives. However, persistent weak demand, competitive pricing, and increased interest expenses due to credit downgrades present ongoing headwinds. Given the mixed performance and the active but uncertain path to recovery in demand, a 'hold' recommendation is appropriate, suggesting investors monitor the effectiveness of deleveraging efforts and signs of demand recovery before making further investment decisions.
Keywords
Chemicals, Specialty Materials, Engineered Polymers, Acetyl Products, Financial Results, SEC Filing, 10-Q, Earnings, Revenue, Profit, Debt, Liquidity, Capital Expenditures, Risk Factors, Corporate Governance, Environmental Liabilities, Taxation, Global Economy, Supply Chain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.